The Filing Desk

Balchem vs Sensient Technologies

Balchem BCPC · Sensient Technologies SXT · Specialty Chemicals

Sensient Technologies reported revenue of $1.6 billion in fiscal 2025, 1.6 times Balchem's $1.0 billion in fiscal 2025. Balchem's revenue grew 8.8% in its latest year, and Sensient Technologies' grew 3.5%. Balchem had an operating margin of 20.2%, against 12.8% at Sensient Technologies. Free cash flow was $173 million at Balchem and $38 million at Sensient Technologies.

Side by side

BalchemSensient Technologies
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$1.0B$1.6B
Revenue growth8.8%3.5%
Revenue growth a year, last 5 years8.1%3.9%
Gross margin35.7%33.5%
Operating margin20.2%12.8%
Net margin14.9%8.3%
Free cash flow$173M$38M
Free cash flow margin16.7%2.4%
Return on capital—8.9%
Net debt to EBITDA—2.5x
Dividends and buybacks$136M$70M
Change in diluted share count−0.3%0.5%
Last close$170.62$131.45
P/E at the last close32.1×35.4×
Insider trades, last 12 monthssold $2.3 millionbought $291,167, sold $234.1 million
Piotroski F-score—6 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
BalchemSensient Technologies
Operating margin
Percent of revenue
BalchemSensient Technologies
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
BalchemSensient Technologies

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Balchem and Sensient Technologies pages.